![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of p... Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Show more
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.ย ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc.ย ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.5 | 2.95683027794 | 16.91 | 17.99 | 16.6901 | 802126 | 17.37472816 | CS |
4 | 2.23 | 14.6903820817 | 15.18 | 17.99 | 14.97 | 810493 | 16.40166092 | CS |
12 | 2.12 | 13.8652714192 | 15.29 | 17.99 | 14.47 | 1077865 | 15.89118582 | CS |
26 | 2.91 | 20.0689655172 | 14.5 | 17.99 | 13.1161 | 1204999 | 15.51310258 | CS |
52 | 4 | 29.8284862043 | 13.41 | 17.99 | 11.55 | 1272013 | 14.63196039 | CS |
156 | 11.86 | 213.693693694 | 5.55 | 22.11 | 4.81 | 1607252 | 13.02635342 | CS |
260 | 12.66 | 266.526315789 | 4.75 | 22.11 | 2.55 | 1707090 | 9.22565492 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions